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ABSTRACT 28 
Functional starter cultures demonstrating superior technological and food safety 29 
properties are advantageous to the food fermentation industry. We evaluated the 30 
efficacy of single and double bacteriocin-producing starters of Lactococcus lactis 31 
capable of producing the Class I bacteriocins, nisin A and/or lacticin 3147 in terms of 32 
starter performance.  Single producers were generated by mobilising the conjugative, 33 
bacteriophage resistance plasmid pMRC01, encoding lacticin genetic determinants, or 34 
the conjugative transposon Tn5276, encoding nisin genetic determinants, to the 35 
commercial starter L. lactis CSK2775. The effect of bacteriocin co-production was 36 
examined by superimposing pMRC01 into the newly constructed nisin transconjugant. 37 
Transconjugants were improved with regard to antimicrobial activity and bacteriophage 38 
insensitivity when compared to the recipient strain and the double producer was 39 
immune to both bacteriocins. Bacteriocin production in the starter was stable, although 40 
the recipient strain proved to be a more efficient acidifier than transconjugant 41 
derivatives. Overall, combining Class I bacteriocins (the double-producer or a 42 
combination of single producers) proved as effective as individual bacteriocins for 43 
controlling Listeria innocua growth in laboratory-scale cheeses. However, using the 44 
double producer in combination with the Class II bacteriocin producer Lactobacillus 45 
plantarum, or the lacticin producer with the Class II producer, proved most effective for 46 
reducing bacterial load.  As emergence of bacteriocin tolerance was reduced 10-fold in 47 
the presence of nisin and lacticin, we suggest that the double producer in conjunction 48 
with the Class II producer could serve as a protective culture providing a food-grade, 49 
multi-hurdle approach to control pathogenic growth in a variety of industrial 50 
applications.  51 
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IMPORTANCE 53 
We generated a suite of single and double-bacteriocin producing starter cultures capable 54 
of generating the Class I bacteriocins lacticin 3147 or nisin or both bacteriocins 55 
simultaneously via conjugation. The transconjugants exhibited improved bacteriophage 56 
resistance and antimicrobial activity. The single producers proved as effective as the 57 
double-bacteriocin producer at reducing Listeria numbers in laboratory-scale cheese. 58 
However, combining the double producer or the lacticin producing starter with a Class 59 
II bacteriocin producer, Lactobacillus plantarum LMG P-26358, proved most effective 60 
at reducing Listeria numbers, and was significantly better than a combination of the 61 
three bacteriocin producing strains, as the double producer is not inhibited by either of 62 
the Class I bacteriocins. Since the simultaneous use of lacticin and nisin should reduce 63 
the emergence of bacteriocin tolerant derivatives this study suggests that a protective 64 
starter system produced by bacteriocin stacking is a worthwhile multi-hurdle approach 65 
for food safety applications. 66 
 67 
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INTRODUCTION 78 
The development and characterisation of starter cultures that demonstrate superior 79 
technological properties such as improved proteolytic activity and flavour production, 80 
exopolysaccharide production or bacteriophage resistance are considered highly 81 
advantageous within the food fermentation industry (1). The ability of starter strains to 82 
produce bacteriocins is also considered an important technological trait for controlling 83 
undesirable and/or pathogenic growth in situ and for improving sensory characteristics 84 
(1-3). Bacteriocins are ribosomally synthesised, heat stable antimicrobial peptides that 85 
generally act by depolarising the target cell membrane and/or through inhibiting cell 86 
wall synthesis where the producing strain is immune to the antimicrobial effect (4). 87 
They comprise a highly heterogeneous group that have recently been divided into three 88 
distinct Classes (5).  89 
The exploitation of bacteriocin-producing cultures is a particularly attractive 90 
option for the food industry owing to the generally recognized as safe (GRAS) status of 91 
the cultures, immediately fulfilling the consumers’ demand for minimally processed 92 
foods lacking artificial food additives. The bacteriocin producer can serve as the starter 93 
culture or be added as an additional protective culture. Several studies have highlighted 94 
the efficacy of such approaches where bacteriocin-producing cultures have proven 95 
effective for inhibiting the growth and proliferation of pathogenic and food spoilage 96 
microorganisms (6-9). Despite this, the use of bacteriocins in the food industry remains 97 
limited possibly owing to the fact that a bacteriocin alone may not be capable of 98 
providing sufficient protection against contamination (10). The use of bacteriocin 99 
combinations or bacteriocin stacking may represent an alternative approach. Indeed, 100 
improved antimicrobial activity of bacteriocin combinations has been reported 101 
previously (11, 12, 13). However, when using multiple bacteriocins, it is essential that 102 
 o
n
 M
ay 11, 2017 by UNIV CO
LLEG
E CO
RK
http://aem
.asm
.org/
D
ow
nloaded from
 
5 
 
other important cultures are not inhibited. This can be overcome to some degree by 103 
developing a multi-bacteriocinogenic culture which is immune to the bacteriocins it 104 
produces. 105 
In the present study, we generated single and double bacteriocin-producing 106 
cultures of L. lactis CSK2775 with the capacity to produce Class I bacteriocins, lacticin 107 
3147 (hereafter lacticin), nisin A (hereafter nisin) or lacticin and nisin. Both 108 
bacteriocins target lipid II to generate pores in the cell membrane causing proton-109 
motive force dissipation and subsequent cell death (14-17). Resulting transconjugants 110 
were assessed for bacteriocin production, bacteriophage resistance properties, 111 
acidification efficiency and antimicrobial activity against a spectrum of indicator strains 112 
including food pathogens and other lactic acid bacteria (LAB). The ability of the 113 
transconjugants (single and double) to produce bacteriocins in laboratory-scale cheese 114 
was assessed and we also evaluated the anti-listerial potential of the Class I producers 115 
alone and in combination with the Class IIa bacteriocin producer Lactobacillus 116 
plantarum LMG P-26358 (18). Class IIa bacteriocins cause pore formation by binding 117 
to and irreversibly opening the sugar transporter mannose phosphotransferase (Man-118 
PTS) system in the target cell (19). In this study, Listeria innocua served as a surrogate 119 
for Listeria monocytogenes for reasons of safety and efficiency (as in many other 120 
studies) and because L. innocua has been successfully used in previous studies 121 
investigating the anti-listerial potential of nisin (20-24), lacticin (25-28) and plantaricin 122 
(18) in food systems.  123 
 124 
 125 
 126 
 127 
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MATERIALS AND METHODS 128 
Bacterial strains and media 129 
Bacterial strains used in this study are listed in Tables 1 and 2. L. lactis strains were 130 
routinely propagated at 30oC in M17 medium (Difco Laboratories, Detroit, MI, USA) 131 
supplemented with 0.5% (w/v) lactose (LM17) or glucose (GM17). Lb. plantarum was 132 
grown in MRS medium (29) (Difco Laboratories) at 30oC. L. innocua was routinely 133 
propagated in GM17 broth at 37oC containing 500 μg/ml streptomycin (Sigma Aldrich, 134 
Ireland). Other media used in this study include BHI (Brain-Heart Infusion) broth 135 
(Oxoid Ltd., Basingstoke, Hampshire, England) and RCM (Re-inforced Clostridial 136 
Medium) (Merck, Darmstadt, Germany). All strains were stored in 50% glycerol at -137 
20oC.  138 
 139 
Strain construction and analytical tests 140 
Strain construction 141 
The conjugation method of Coakley et al. (30) was used with slight modifications to 142 
generate lacticin transconjugants. Inocula (2%) of both donor and recipient were grown 143 
for 4 h in GM17 broth at 30oC. After the growth period, 1 ml of recipient and 1 ml of 144 
donor were harvested by centrifugation (16,000 x g for 1 min) and rinsed twice with 145 
GM17 broth. After the final rinse, each strain was resuspended in 50 μl of GM17 broth. 146 
The concentrated recipient and donor (20x) were then mixed with each other at the 147 
following ratios, 1:1, 2:1 and 20:1. Each mixture was spotted onto the centre of a GM17 148 
agar plate and incubated for 18 h at 30oC. The following day, spots were harvested in 1 149 
ml of maximum recovery diluent (MRD; Oxoid) and serially diluted before plating on 150 
lactose indicator agar (LIA) containing lacticin (400 arbitrary units (AU)/ml) as 151 
described previously (30). Following 48 h of incubation at 30oC the lacticin-containing 152 
 o
n
 M
ay 11, 2017 by UNIV CO
LLEG
E CO
RK
http://aem
.asm
.org/
D
ow
nloaded from
 
7 
 
LIA plates were examined for lactose-positive colonies (yellow) against a background 153 
of lactose-negative colonies (white), and lactose-positive colonies were selected and 154 
grown in LM17 broth for further analysis.  155 
Nisin transconjugants were generated according to the method of Gireesh et al. (31) 156 
with modifications: inocula of donor (1.5%) and recipient (2%) were grown for 4 h in 157 
GM17 broth at 30oC. Donor and recipient were then mixed at the following ratios, 1:10 158 
and 1:100 in the presence of 400 μg/ml α-chymotrypsin (Sigma Aldrich). The cells 159 
were collected onto membrane filters (0.45 μm pore size, Merck, Millipore, Darmstadt, 160 
Germany) after which the filters were placed on GM17 agar plates (cell side down). 161 
Following 18 h of incubation at 30oC, cells were harvested from the filter and added to 162 
10% reconstituted skimmed milk (RSM) containing 400 AU/ml nisin (Sigma Aldrich) 163 
and incubated at 30oC for 24-48 h. Clotted samples were serially diluted, plated on LIA 164 
and following 48 h of incubation at 30oC, yellow colonies were selected for further 165 
analysis.   166 
 167 
Bacteriocin production and immunity 168 
Bacteriocin production and immunity was assessed by performing the agar well 169 
diffusion assay as described by Ryan et al. (32). Indicator organisms are listed in Table 170 
2. Bacteriocin sensitivity was scored according to the diameter of the zone of inhibition 171 
surrounding the well which contained cell free supernatant from the bacteriocin 172 
producer. The concentration of bacteriocin produced by the double producer was 173 
measured by agar well diffusion assay using a serial two-fold dilution of the filtered 174 
culture supernatant and bacteriocin activity was calculated as the inverse of the last 175 
dilution that gave a definite zone of clearance after overnight incubation where AU 176 
were expressed per ml. 177 
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Colony mass spectrometry  178 
Colony mass spectrometry was performed according to the method described by Field 179 
et al. (33).  180 
 181 
PCR scan 182 
Genomic DNA was extracted from 1.5 ml of 18 h cultures according to the method of 183 
Hoffman and Winston (34) slightly modified as described previously (35). Primer pairs 184 
used to scan strains for the presence of pMRC01 as well as the genes associated with 185 
nisin production are listed in Table 3. PCR was performed in a Hybaid PCR express 186 
unit (Hybaid Ltd., Middlesex, UK) using MyTaqTM Red Mix polymerase (Bioline Ltd., 187 
London, U.K.) according to manufacturers’ specifications combined with an annealing 188 
temperature of 55oC.  189 
 190 
Pulsed field gel electrophoresis 191 
Pulsed field gel electrophoresis (PFGE) was performed according to Mills et al. (35) 192 
using the restriction enzyme SmaI (New England Biolabs, Hertfordshire, U.K.). DNA 193 
fragments were run on a CHEF-DR III pulsed-field system (Bio-Rad laboratories, 194 
California, USA) at 6V/cm for 22 h with a 1-30 s linear ramp pulse time. Molecular size 195 
markers (N0340S, N0350S) were purchased from New England BioLabs. 196 
 197 
Bacteriophage assays 198 
Bacteriophages were propagated according to the method outlined previously (36). 199 
Sensitivity to bacteriophage infection was performed by the double agar layer plaque 200 
assay as described previously (30).   201 
 202 
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Characterisation of acid production 203 
Acid production was monitored in 10% RSM in the presence and absence of 0.1% yeast 204 
extract according to the method of Harrington and Hill (37). 205 
 206 
Laboratory-scale cheese manufacture 207 
Cultures were grown from frozen stocks in their respective media for 18 h (Table 1). 208 
The cultures were then inoculated at 1% (v/v) into 10% (w/v) RSM and incubated for a 209 
further 18 h at 30oC. In the case of Lb. plantarum LMG P-26358, the culture was grown 210 
in 10% RSM containing 0.1% (v/v) yeast extract and 0.2 g/l MnSO44H2O as previously 211 
reported (18).  212 
One litre vats of whole milk heated to 31oC were inoculated with the 18 h RSM cultures 213 
as follows:  214 
-Vat 1 = 0.75% (v/v) L. lactis DPC4268, 0.75% (v/v) L. lactis CSK2775 (no 215 
bacteriocin) 216 
-Vat 2 = 0.75% (v/v) L. lactis DPC4268, 0.75% (v/v) L. lactis CSK3281 (nisin 217 
producer) 218 
-Vat 3 = 0.75% (v/v) L. lactis DPC4268, 0.75% (v/v) L. lactis CSK3594 (lacticin 219 
producer) 220 
-Vat 4 = 0.75% (v/v) L. lactis DPC4268, 0.75% (v/v) L. lactis CSK3533 (nisin-lacticin 221 
double producer) 222 
-Vat 5 = 0.75% (v/v) L. lactis DPC4268, 0.5% (v/v) L. lactis CSK3281 (nisin 223 
producer), 0.5% (v/v) Lb. plantarum LMG P-26358 (plantaricin producer) 224 
-Vat 6 = 0.75% (v/v) L. lactis DPC4268, 0.5% (v/v) L. lactis CSK3594 (lacticin 225 
producer), 0.5% (v/v) Lb. plantarum LMG P-26358 (plantaricin producer) 226 
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-Vat 7 = 0.75% (v/v) L. lactis DPC4268, 0.5% (v/v) L. lactis CSK3533 (nisin–lacticin 227 
double producer), 0.5% (v/v) Lb. plantarum LMG P-26358 (plantaricin producer) 228 
-Vat 8 = 0.75% (v/v) L. lactis DPC4268, 0.5% (v/v) CSK3594 (lacticin producer), 0.5% 229 
(v/v) CSK3281 (nisin producer) 230 
-Vat 9 = 0.75% (v/v) L. lactis DPC4268, 0.5% (v/v) CSK3594 (lacticin producer), 0.5% 231 
(v/v) CSK3281 (nisin producer), 0.5% (v/v) Lb. plantarum LMG P-26358 (plantaricin 232 
producer) 233 
A streptomycin resistant derivative of L. innocua (DPC6578) grown for 18 h was added 234 
to each vat at a level of 104 cfu/ml. Thirty min after inoculation, 150 international milk 235 
clotting units/ml Kalase rennet (CSK Food Enrichment, The Netherlands) was added 236 
according to manufacturer’s specifications and after a further 15 min the curd was cut 237 
into cubes. Following a 10 min stirring step, approximately 35% of the whey was 238 
removed and the curd was stirred for a further 5 min. The temperature was then 239 
elevated to 36oC over a 5 min period and the curd was stirred for a further 20 min. The 240 
curd was further drained and lightly pressed into moulds for 20 min before pressing 241 
overnight. After 24 h the cheeses were submerged in a brine bath (23% NaCl [w/v], 242 
0.22% phosphoric acid [v/v], 0.1% NaOH [w/v], 0.6% CaCl2 [w/v]) at 10-12oC for 5 h 243 
after which they were vacuum-packed and ripened at 7oC for 4 weeks. L. innocua 244 
DPC6578 was enumerated in each cheese on a weekly basis by homogenising 1 g of 245 
cheese in 2% sterile tri-sodium citrate and plating serial dilutions on selective medium 246 
(GM17 agar with 500 μg/ml of streptomycin). The cheese trial was performed in 247 
triplicate and sampling for each trial was performed in duplicate.  248 
Nisin (3352 ± 3 Da), lacticin (Ltnβ: 2847 ± 4 Da) and plantaricin (3928 ± 3 Da) present 249 
within cheese samples from Vats 4, 5, 6, and 7 were verified by MALDI-TOF mass 250 
spectrometry (MALDI-TOF MS) as described previously (18). In the case of lacticin, 251 
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the presence of the correct mass for Ltnβ was indicative of lacticin since Ltnα can be 252 
difficult to detect in a complex fraction. All fractions were tested for antimicrobial 253 
activity by agar well diffusion assays against the appropriate indicator strains (lacticin 254 
and nisin against L. lactis HP; plantaricin against L. innocua) where mass and 255 
concomitant activity were indicative of bacteriocin presence. Fractions expected to 256 
contain the lacticin peptides (23/24: Ltnα and 37: Ltnβ) were combined or wells were 257 
positioned near each other to assess lacticin activity.  258 
 259 
Frequency of bacteriocin resistance/tolerance 260 
To determine the frequency of bacteriocin resistance/tolerance development in L. 261 
innocua, freshly prepared 18 h cultures were serially diluted in MRD and spread plated 262 
on to GM17 or GM17 containing either 1000 AU/ml or 320 AU/ml of the appropriate 263 
bacteriocin or bacteriocin combination, the latter concentration representing the 264 
arbitrary in situ concentration of the bacteriocins in the cheeses. Plates were incubated 265 
aerobically at 37°C for up to 48h, at which time, the frequency of bacteriocin 266 
resistance/tolerance was calculated as described previously (38). All experiments were 267 
performed in triplicate.  268 
 269 
Statistical Analysis 270 
Listeria counts in laboratory-scale cheeses were statistically analyzed using one-way 271 
ANOVA. Post hoc multiple comparisons were determined by Tukey’s test and 272 
differences were considered to be statistically significant at P<0.05. Statistical tests 273 
were performed using XLSTAT statistical software.   274 
 275 
 276 
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RESULTS 277 
Transconjugant validation 278 
The presence of the plasmid, pMRC01, and the nisin transposon, Tn5276, in L. lactis 279 
CSK2775 transconjugants was validated by PCR using plasmid- and transposon-280 
specific primers, respectively (Fig. 1). PCR analysis confirmed that the genetic 281 
determinants responsible for lacticin production were present in 2775 (pMRC01) 282 
creating the lacticin transconjugant L. lactis CSK3594, and confirmed the presence of 283 
the nisin genetic determinants in 2775 (Tn5276) creating the nisin transconjugant 284 
CSK3281. The presence of the lacticin and nisin genetic determinants was confirmed in 285 
the double producer resulting in the nisin-lacticin transconjugant L. lactis CSK3533. To 286 
confirm the identity of each transconjugant, genomic fingerprints were generated by 287 
PFGE with the restriction endonuclease, SmaI. All transconjugants analysed generated 288 
the same restriction pattern as the recipient strain, CSK2775 (results not shown). Well 289 
diffusion assays confirmed that CSK3594 was sensitive to nisin and that CSK3281was 290 
sensitive to lacticin but the double producer was immune to both bacteriocins. 291 
Colony mass spectrometry (CMS) confirmed that CSK3594 and CSK3533 each 292 
produced a peptide with a mass of approximately 2847 ± 4 Da corresponding to the 293 
lacticin peptide, Ltnβ (Fig. 2). However, lacticin peptides (Ltnα or Ltnβ) could not be 294 
detected in the recipient strain, CSK2775 (Fig. 2). CMS also detected a peptide with a 295 
mass of 3352 ± 3 Da corresponding to nisin in strains CSK3281 and CSK3533; this 296 
peptide was absent in the recipient strain. These data confirm that lacticin is produced 297 
by CSK3594, nisin is produced by CSK3281, and that both nisin and lacticin are 298 
produced by CSK3533 (Fig. 2).  299 
The level of inhibitory activity in the culture supernatant of the double producer, 300 
CSK3533, against L. lactis HP was determined to be 1000 AU/ml when measured by 301 
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agar well diffusion assays, corresponding to a zone size of 4.5 mm which is equivalent 302 
to the zone size produced by the nisin transconjugant L. lactis CSK3281. The lacticin 303 
transconjugant, CSK3594 produced a 2.5 mm zone against L. lactis HP. To our 304 
knowledge, this is the first report of the successful construction of a food-grade 305 
commercial L. lactis starter strain capable of producing both nisin and lacticin 3147, 306 
two potent Class I bacteriocins. 307 
 308 
Strain performance and stability 309 
The stability of the bacteriocin/lactose positive phenotype in each transconjugant was 310 
confirmed via repeated “passaging” in GM17 followed by bacteriocin activity assays 311 
against the indicator, L. lactis HP. Bacteriocin production and immunity in CSK3281, 312 
CSK3594 and CSK3533 proved to be stable over time. However, upon passaging of the 313 
double producer, CSK3533, in GM17, a mixed culture containing lactose fermenting 314 
and non-fermenting colonies could be observed when plated on LIA. This mixed culture 315 
was subsequently attributed to the loss of a large plasmid (>50 kb) present in CSK3533 316 
(confirmed by plasmid profile analysis; results not shown) and is presumed to be 317 
involved in lactose metabolism. The lactose fermenting phenotype could be preserved 318 
through the supplementation of lactose to the growth medium.  319 
Comparative analyses of acidification profiles of each transconjugant and the 320 
recipient strain revealed that the bacteriocin-free recipient, CSK2775, proved to be the 321 
most efficient acidifier (Fig. 3). Although the lacticin single producer (CSK3594) was 322 
more efficient than the nisin single producer (CSK3281), both proved to be more 323 
efficient than the double producer, CSK3533 (Fig. 3). The addition of 0.1% yeast 324 
extract improved lactic acid production in the transconjugants.  325 
 326 
 o
n
 M
ay 11, 2017 by UNIV CO
LLEG
E CO
RK
http://aem
.asm
.org/
D
ow
nloaded from
 
14 
 
Spectrum of inhibition and bacteriophage resistance  327 
The activity of the single bacteriocin producers CSK3594 and CSK3281 as well as the 328 
double producer, CSK3533, were assayed against a range of indicator strains including 329 
food spoilage, pathogenic bacteria, as well as LAB, and non starter LAB (NSLAB) 330 
(Table 2). The single lacticin producer was found to inhibit primarily lactococci, 331 
lactobacilli, and clostridia while a wider spectrum of inhibition was observed for both 332 
the nisin producer and the double producer. The double producer proved to be more 333 
effective than either lacticin or nisin single producers with regard to Clostridium 334 
tyrobutyricum inhibition producing a 6 mm zone while the lacticin producer, CSK3594, 335 
and nisin producer, CSK3281, each produced zones of 4 mm and 3 mm, respectively. 336 
Interestingly, the recipient strain, CSK2775, also produced a 1 mm zone against 337 
Clostridium tyrobutyricum suggesting that some other antimicrobial effect is potentially 338 
working in conjunction with the bacteriocins in the transconjugants. In addition, the 339 
double producer generated a 4 mm zone against CSK3281 in comparison to a 2.5 mm 340 
zone produced by CSK3594. This increase in zone size is surprising given that 341 
CSK3281 harbours the genetic machinery for nisin immunity and indeed was proven to 342 
be immune to nisin in the antimicrobial assays. However, the increased susceptibility of 343 
the nisin transconjugant to lacticin may be due to a lower cell density in the seeded 344 
plate as a consequence of a slower growth rate although this has not been confirmed.  345 
Bacteriophage sensitivity assays confirmed that CSK2775, the non-346 
bacteriocinogenic recipient, was sensitive to all bacteriophages analysed (Table 4). The 347 
nisin producer, CSK3281 was resistant to 50% of the bacteriophages analysed, while 348 
the lacticin single producer and the double producer were each resistant to 80% of 349 
bacteriophages analysed (Table 4).  350 
 351 
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Laboratory-scale cheese production 352 
To analyse the in situ inhibitory activity of the bacteriocin producers (single, double and 353 
in combination with the plantaricin producer, Lb. plantarum LMG P-26358) laboratory-354 
scale cheeses were manufactured with the fast acidifier L. lactis DPC4268 and the 355 
bacteriocin producers served as protective cultures. The cheeses were spiked with 104 356 
cfu/ml of L. innocua. Each cheese was ripened for 4 weeks at 7°C; Listeria was 357 
enumerated weekly during the ripening period. Fig. 4 shows Listeria viable cell counts 358 
over the 4 week period where bacteriocin containing vats were compared with Vat 1 (no 359 
bacteriocin) at each week.  At week 0, Listeria numbers were significantly different 360 
between Vat 1 (5.6 log cfu/g) and all other vats with lowest Listeria numbers recorded 361 
for vat 7 (CSK3533; Lb. plantarum) at 3.5 log cfu/g (P<0.001), followed by Vat 2 362 
(CSK3281) at 3.8 log cfu/g (P<0.001). Listeria numbers in the remaining vats were 363 
reduced by 0.9 to 1.5 logs when compared to Vat 1. By week 1, Listeria numbers in Vat 364 
7 continued to decrease significantly compared to Vat 1 with a 3 log reduction recorded 365 
(P<0.001). Listeria numbers in Vat 6 (CSK3594; Lb. plantarum) were also significantly 366 
different to Vat 1 with a 2.7 log reduction (P<0.001). Significant reductions were also 367 
observed for Vat 9 (CSK3281; CSK3594; Lb. plantarum) (1.6 log reduction; P<0.01) 368 
and Vat 5 (CSK3281; Lb. plantarum) (0.8 log reduction; P<0.05). At week 2 lowest 369 
Listeria numbers were recorded for Vat 6 (0.4 log cfu/g) and Vat 7 (0.7 log cfu/g) 370 
representing 2.6 and 2.3 log reductions compared to Vat 1 (3 log cfu/g) (P<0.01). Vat 5 371 
(CSK3281; Lb. plantarum) was also significantly different to Vat 1 (1.8 log reduction; 372 
P<0.01). By week 3, Vat 7 exhibited lowest Listeria numbers (0.4 log cfu/g) followed 373 
by Vat 9 (0.8 log cfu/g), which were both significantly different to Vat 1 (2.5 log cfu/g) 374 
(P<0.05). By the week 4, Listeria numbers for Vat 1 (2.9 log cfu/g) were significantly 375 
different to most other Vats, with no Listeria detected in Vat 6 (P<0.01) and numbers 376 
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reduced to 0.3 log cfu/g for Vat 7 (P<0.01). Listeria numbers in the remaining vats (2, 377 
3, 4, 8, 9) ranged from 0.8 to 1 log cfu/g representing significant differences compared 378 
to Vat 1 (P<0.05). While, Listeria numbers in Vat 5 were not deemed significantly 379 
different to Vat 1, they approached a significant reduction (P=0.07).  380 
In terms of the lacticin and nisin transconjugants (without Lb. plantarum), no 381 
significant differences were observed between the double producer (Vat 4) and either of 382 
the single producers (Vats 2 and 3) with regards to Listeria numbers at any week. We 383 
then compared Vat 8 which consists of the two single producers (CSK3281; CSK3594) 384 
(4.4 log cfu/g; week 0) with Vats 2, 3 and 4. While Vat 8 was found to be significantly 385 
different to Vat 2  (3.7 log cfu/g) at week 0 (P<0.05) whereby the nisin producer 386 
generated greater Listeria reductions than the combination of nisin and lacticin single 387 
producers, no significant differences were observed for weeks 1-4. Likewise, no 388 
significant differences were observed between Vat 8 and Vats 3 or 4 over the ripening 389 
period.  390 
 391 
Bacteriocin detection in Vats 4, 5, 6 and 7 392 
The correct masses for nisin (fraction 21), Ltnβ (fraction 37) and plantaricin (fraction 393 
19) were detected by MALDI-TOF MS in Vat 7 (double producer and plantaricin) at 394 
week 0 (Fig 5A). Antimicrobial assays also revealed that these fractions contained 395 
activity (lacticin activity was restored by combining fractions 23 (Ltnα) and 37).  396 
At week 4, a mass corresponding to plantaricin was detected in fraction 19 but there 397 
was no antimicrobial activity. Nisin was detected in fraction 21 at week 4 and activity 398 
was also confirmed. The correct mass for Ltnβ could not be detected at week 4. Despite 399 
this, combining fractions 23 and 37 did yield a zone of inhibition against the indicator 400 
strain, suggesting the bacteriocin is present.  401 
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The correct mass for nisin was not detected in Vat 4 (double producer) at weeks 402 
0 or 4, however, fraction 21, which is generally expected to contain nisin, yielded a 403 
zone of inhibition against the indicator strain on both weeks, suggesting the bacteriocin 404 
is present (Fig 5B). The correct mass for Ltnβ was detected in Vat 4 (double producer) 405 
at weeks 0 and 4 (Fig 5B). Lacticin activity was confirmed when fractions 23 and 37 406 
were positioned beside each other in the agar well diffusion assays.  407 
Vat 5 (nisin and plantaricin) was found to contain the nisin mass at weeks 0 and 408 
4 although the correct mass was found in fraction 22 at week 0 and in fraction 23 at 409 
week 4 (Fig 5C). This is presumably due to slight variations in the times the peptide 410 
eluted from the HPLC. These fractions exhibited antimicrobial activity against the 411 
indicator strain but the zones were smaller than previously observed. The plantaricin 412 
mass was not detected in Vat 5 at week 0 but a zone of inhibition against Listeria was 413 
observed for fraction 19. However, the plantaricin mass was detected in Vat 5 at week 4 414 
and antimicrobial activity was confirmed.   415 
Vat 6 (lacticin and plantaricin) was shown to contain the correct Ltnβ and plantaricin 416 
masses at weeks 0 and 4 in fractions 37 and 19, respectively (Fig 5D). Antimicrobial 417 
activity was confirmed for fraction 19 although the zone was smaller at week 0 when 418 
compared to week 4. In the case of lacticin, combining fractions 24 (Ltnα) and 37 419 
confirmed antimicrobial activity.  420 
 421 
Development of bacteriocin tolerance  422 
The frequency of tolerance/resistance development in L. innocua was assessed using 423 
1000 AU/ml of each bacteriocin. The frequency of resistance against 1000 AU/ml of 424 
nisin was calculated to be 6.56 x 10-4. Resistance development could not be observed 425 
when Listeria was exposed to 1000 AU/ml lacticin or 1000 AU/ml nisin and lacticin. 426 
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On the other hand, the frequency of resistance development against 320 AU/ml nisin or 427 
320 AU/ml lacticin (representing arbitrary concentrations in cheese) was much lower at 428 
4.9 x 10-1 and 3.02 x 10-1, respectively. Simultaneous exposure to lacticin and nisin at 429 
320 AU/ml decreased the frequency of resistance to 3.18 x 10-2. However, bacteriocin 430 
resistant colonies remained sensitive to 1000 AU/ml indicating that Listeria cells were 431 
tolerant rather than completely resistant.  432 
 433 
 434 
 435 
 436 
 437 
 438 
 439 
 440 
 441 
 442 
 443 
 444 
 445 
 446 
 447 
 448 
 449 
 450 
 451 
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DISCUSSION 452 
In this study, an isogenic family of nisin and lacticin transconjugants was developed 453 
with a view to better understand the impact of multiple bacteriocin production and 454 
genetic load on starter culture functionality. Genotypic and phenotypic analyses 455 
including PCR, well diffusion assays and CMS confirmed the acquisition of lacticin 456 
and/or nisin in each transconjugant.  457 
In agreement with previous findings (39) which revealed that pMRC01 imposes 458 
a burden on lactococcal metabolism affecting growth and acidification rates, the 459 
presence of pMRC01 was shown to influence lactococcal acidification in the lacticin 460 
transconjugant, as did the presence of the nisin transposon in the nisin transconjugant. 461 
However, bacteriocin stacking resulted in slowest acidification rates but which can be 462 
overcome with the addition of 0.1% yeast extract to the double producer. Yeast extract 463 
presumably lessens the burden of plasmid and transposon acquisition as it provides 464 
amino acids along with purine and pyrimidine bases and inorganic constituents which 465 
have been shown to stimulate lactococcal growth (40). We therefore suggest that the 466 
double producer has potential to serve as a protective culture when used in conjunction 467 
with a suitable acidifier.  Despite this, the lactose utilization phenotype in the double 468 
producer, CSK3533, was found to be unstable in GM17 apparently due to the loss of a 469 
large (>50kb) plasmid likely involved in lactose utilization. Both the plasmid instability 470 
and slower acidification profiles observed in the double producer (CSK3533) may be 471 
attributed to the metabolic burden imposed by the presence of pMRC01 and the nisin 472 
transposon. In an effort to ease the metabolic load, it is possible that as the energy 473 
demand of the cell increases and metabolites are exhausted, a reduction in growth rate 474 
and perhaps the loss of nonessential plasmids may occur (39, 41). This is supported by 475 
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the fact that the addition of lactose to M17 broth maintains the lactose utilization 476 
phenotype in the double producer.  477 
Antimicrobial activity assays confirmed that co-production of nisin and lacticin 478 
by CSK3533 was as effective as its single producing counterparts against most of the 479 
indicator strains tested. This indicates that bacteriocin production is not affected by the 480 
slower growth rate observed in the double producer. Furthermore, with the exception of 481 
C. tyrobutyricum, the co-production of the two potent bacteriocins did not result in an 482 
increase in antimicrobial activity. Studies suggest that bacteriocin production and 483 
subsequent inhibition may be influenced by growth medium (42, 43). The multi-484 
bacteriocinogenic strain L. lactis INIA 415 was capable of producing the Class I 485 
bacteriocin lacticin 481 in M17 broth only and produced nisin in milk only (42). 486 
Therefore, it is possible that growth of CSK3533 under different conditions could result 487 
in higher levels of nisin or lacticin being produced.  488 
In terms of bacteriophage resistance, transconjugants were shown to be more 489 
resistant to bacteriophage attack than the recipient strain with superior resistance 490 
properties observed in pMRC01 derivatives, which is known to harbour an abortive 491 
infection mechanism (30).  492 
Laboratory-scale cheese inoculated with Listeria was used to assess the efficacy 493 
of single and double bacteriocin producers alone and in combination with the 494 
plantaricin producer, Lb. plantarum LMG P-26358 in situ. The latter strain was 495 
previously shown to have a narrow spectrum of inhibition, inhibiting Listeria and 496 
enterococcal strains but not clostridia, E. coli, Bacillus species, Salmonella, or members 497 
of the LAB (18). The strain proved to be an effective adjunct for controlling Listeria 498 
growth in a cheese model (18). In the present study, CSK3594, CSK3281 and CSK3533 499 
failed to inhibit L. innocua by agar well diffusion assay, however, by the end of the 500 
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ripening period, Listeria numbers from cheeses prepared with these starters were 501 
significantly reduced when compared to the control, Vat 1 (no bacteriocin). 502 
Interestingly, the double producer combined with the plantaricin producer exhibited the 503 
greatest reduction in Listeria numbers at week 0, a trend which continued to Week 1 504 
suggesting the effectiveness of this combination for reducing initial bacterial load. The 505 
inhibitory effect of this combination was on the whole significantly better than using 506 
both single producers with the plantaricin producer. This can be explained by the fact 507 
that the nisin producing transconjugant inhibits the lacticin transconjugant and vice 508 
versa whereas the double producer is immune to both bacteriocins. The combination of 509 
the lacticin producer with Lb. plantarum LMG P-26358 also significantly reduced 510 
Listeria numbers by week 1 and indeed by week 4, Listeria could not be detected in this 511 
vat. Overall, the double producer combined with the plantaricin producer followed by 512 
the lacticin producer combined with plantaricin exhibited the most significant 513 
reductions in Listeria numbers over the ripening period.  514 
In general, a similar inhibitory trend was observed amongst the single Class I 515 
producers, the double producer or the combined single producers which were 516 
significantly different to Vat 1 at week 0 and week 4. While the double producer did not 517 
alter Listeria numbers significantly when compared to the single producers alone, a 10-518 
fold reduction in the emergence of bacteriocin tolerance was observed when Listeria 519 
was exposed to both nisin and lacticin, suggesting that bacteriocin stacking could be an 520 
effective method to prevent pathogen growth in food applications. However, combining 521 
bacteriocins from different Classes or sub-classes is considered most effective for 522 
reducing the emergence of resistance (44) which explains the increased antimicrobial 523 
efficacy for vats containing the Class I and Class II bacteriocins in this study.  524 
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Interestingly, cheese prepared with non-bacteriocinogenic CSK2775 also 525 
resulted in reduced Listeria numbers over the four week period although to a lesser 526 
extent than the bacteriocin containing cheeses. Therefore, it is probable that bacterial 527 
competition coupled with unfavourable conditions relating to cheese manufacture 528 
including lactic acid and high salt concentrations have provided a hurdle-effect to cause 529 
the observed reductions. Indeed, several intrinsic factors including moisture content, 530 
acidity and competitive flora are known to dictate pathogen survival in cheese (45, 46). 531 
MALDI-TOF MS of cheeses from vats 4, 5, 6 and 7 indicated that nisin and 532 
lacticin were present in the appropriate cheeses implying that bacteriocin integrity was 533 
not compromised in the cheese environment. The presence of plantaricin could not be 534 
confirmed in Vat 7 cheese (double producer and plantaricin) at week 4 but it was 535 
present in vats 5 and 6 at both times as expected. MALDI-TOF MS is not quantitative 536 
and is also subject to preferential ionisation in that some peptides ionise better than 537 
others. The peptide content in a cheese increases during ripening due to the breakdown 538 
of casein so a number of bacteriocin purification steps were performed to increase the 539 
chances of detecting bacteriocin masses. Cheeses were passed through C18 SPE 540 
columns and peptides were further separated using RP-HPLC. Each HPLC fraction 541 
potentially contains numerous peptides making it difficult to detect the bacteriocin 542 
masses which are present at low concentrations. Usually the bacteriocin mass and a 543 
concomitant zone of inhibition is taken as proof of the presence of bacteriocin but in the 544 
case of a cheese fraction the presence of a zone of inhibition alone may be taken as 545 
indicative of bacteriocin presence. 546 
 Natural isolates capable of producing multiple bacteriocins have been reported 547 
in the literature (47-51). Most recently, L. lactis LMG2081 was shown to produce two 548 
different Classes of bacteriocins, a novel lantibiotic and the Class IIb bacteriocin, 549 
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lactococcin G (52). However, the ability to generate a multi-bacteriocin producer from 550 
an already established culture through food-grade enabling technologies poses several 551 
benefits. Firstly, the technological properties of the culture are known. The number of 552 
cultures required to produce multiple bacteriocins is reduced. The risk of bacteriocin 553 
inhibition is removed since the multibacteriocin-producing starter will also harbour the 554 
genetic machinery for bacteriocin immunity. As conjugation is a natural process, the 555 
resulting transconjugants do not fall under current European regulations governing the 556 
use of genetically modified microorganisms (53, 54). Therefore, transconjugants can be 557 
used in food applications in a similar manner to the recipient strain (55). While the 558 
double bacteriocin producer generated in this study proved to be a slower acidifier than 559 
the recipient strain, it has potential to serve as a protective culture. However, studies 560 
generating multiple bacteriocin producers have been rare (13). This can most likely be 561 
attributed to the complex biosynthetic process required for bacteriocin production and 562 
secretion. Indeed, previous attempts to construct nisin-lacticin transconjugants were 563 
unsuccessful, often attributed to the incompatibility of bacteriocin modification 564 
machinery or bacteriocin sensitivity (13, 30). Traditionally, the discovery of 565 
technologically valuable industrial strains has focused on large-scale screening 566 
strategies from a variety of sources (56). However, the successful transfer of lacticin 567 
and nisin to commercial starter cultures as reported in this study may provide additional 568 
avenues for the development of multi-hurdle protective cultures using food-grade 569 
methods.  570 
 571 
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FIG 1 PCR amplification using pMRC01-specific primers (orf27, orf49, orf51, and 826 
orf52) to detect the presence of pMRC01 in L. lactis CSK3594 and CSK3533. PCR 827 
amplification using primers designed to regions of the nisin operon (nisA, nisFEG) to 828 
confirm the presence of nisin genetic determinants in L. lactis CSK3281 and L. lactis 829 
CSK3533. (M: 100 bp DNA ladder; New England BioLabs).  830 
FIG 2 Colony mass spectrometry analysis of L. lactis CSK2775, L. lactis CSK3594 831 
(lacticin transconjugant, Ltn+), L. lactis CSK3281 (nisin transconjugant, Nis+) and L. 832 
lactis CSK3533 (nisin and lacticin double producer, Ltn+, Nis+). Masses corresponding 833 
to the bacteriocins are indicated. Inset photos show inhibition zones produced by each 834 
strain against the indicator strain L. lactis HP. 835 
FIG 3 Acidification profiles of L. lactis CSK2775 ( ); L. lactis CSK3594 (lacticin) 836 
( ); L. lactis CSK3281 (nisin) ( ); and L. lactis CSK3533 (nisin, lacticin) ( ) grown 837 
in 10% RSM. 838 
FIG 4 Counts of viable L. innocua cells in laboratory-scale cheeses. Bacteriocin-839 
containing vats were compared to Vat 1 (no bacteriocin) at each week (* P<0.05; ** 840 
P<0.01; *** P<0.001).  841 
FIG 5 MALDI-TOF MS analysis of Vat 7 (lacticin, nisin and plantaricin) (A), Vat 4 842 
(lacticin and nisin) (B), Vat 5 (nisin and plantaricin) (C) and Vat 6 (lacticin and 843 
plantaricin) (D). Masses corresponding to the bacteriocins are indicated. Inset photos 844 
show inhibition zones produced by correct mass-containing fractions against the 845 
indicator strains L. lactis HP (nisin and lacticin) or L. innocua (plantaricin) where F 846 
denotes Fraction. 847 
 848 
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 850 
 851 
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TABLE 1 Bacterial strains used in this study 854 
aLac, lactose utlization; Ltn, lacticin genetic determinants; Nis, nisin genetic determinants; Pln, 855 
plantaricin genetic determinants. 856 
b TFRC, Teagasc Food Research Centre, Moorepark, Fermoy, County Cork, Ireland. 857 
 858 
 859 
 860 
 861 
 862 
 863 
 864 
 865 
 866 
 867 
 868 
 869 
 870 
 871 
 872 
 873 
Bacterial strain Relevant Detail Relevant genotype 
and phenotypea 
Source or reference 
L. lactis HP Bacteriocin sensitive indicator strain Ltn-; Nis- TFRCb  
L. lactis MG1363 
(pMRC01) 
Donor strain harbouring pMRC01, 
lacticin producer 
Lac-; Ltn+; Nis- TFRC  
L. lactis CSK2583 Donor strain harbouring Tn5276, nisin 
producer  
Lac-; Nis+; Ltn- CSK, The Netherlands 
L. lactis CSK2775 Recipient strain Lac+; Nis-; Ltn- CSK, The Netherlands 
L. lactis CSK3281 CSK2775 derivative, nisin producer Lac+; Nis+ This study 
L. lactis CSK3594 CSK2775 transconjugant harbouring 
pMRC01, lacticin producer 
Lac+; Ltn+ This study 
L. lactis CSK3533 CSK3281 transconjugant harbouring 
pMRC01, nisin-lacticin double producer 
Lac+; Nis+, Ltn+ This study 
Lb. plantarum LMG P-
2658 
Plantaricin 423 producer Pln+ (18) 
L. lactis DPC4268 Starter culture for cheese manufacture Lac+ TFRC 
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TABLE 2 Antimicrobial spectrum of the L. lactis isogenic family of nisin and lacticin transconjugants 874 
Indicator Strain or Species  Growth 
Medium  
Strains Tested for Antimicrobial Activity Source 
CSK2275  CSK3594  (Ltn) CSK3281 (Nis) CSK3533 (Ltn, Nis) 
Bacillus cereus DPC6085/6086  BHIa  No zone  No zone  1mm zone  1mm zone  TFRC  
Bacillus subtilus DPC6511  BHIa  No zone  No zone  No zone  No zone  TFRC 
Enterococcus faecalis DPC5055/LMG 7973  BHIa  No zone  No zone  3mm zone  3mm zone  TFRC 
Enterococcus faecium  DPC5056* BHIa  No zone  No zone  6mm zone  6mm zone  TFRC 
Escherichia coli P1432- DPC6054  BHIa  No zone  No zone  No zone  No zone  TFRC 
Clostridium sporogenes DPC6341*  RCMa  No zone   1.5 mm zone  1.5mm zone  1mm zone  TFRC 
Clostridium tyrobutyricum DPC6342*  RCMa  1mm zone  4mm zone  3mm zone  6mm zone  TFRC 
Lactobacillus casei DPC6125  MRSc  No zone  No zone  7mm zone  7mm zone  TFRC 
Lactobacillus acidophilus DPC5378  MRSa  No zone  1mm zone  3mm zone  3mm zone  TFRC 
Lactobacillus delbreukii subsp. delbreukii DPC5385  MRSa  No zone  No zone  6mm zone  6mm zone  TFRC 
Lb. delbreukii subsp. lactis DPC5387  MRSc  No zone  1.5mm zone  6mm zone  6mm zone  TFRC 
Lb  delbreukii subsp. bulgaricus DPC5383  MRSc  No zone  2mm zone  9.5mm zone  9.5mm zone  TFRC 
Lactobacillus helveticus DPC4571  MRSa  No zone  1.5mm zone  8mm zone  8mm zone  TFRC 
L .lactis subsp. lactis biovar diacetyllactis CSK1411  LM17b  No zone  1.5mm zone  4mm zone  4mm zone  CSK  
L. lactis subsp. cremoris HP DPC5718  LM17c  No zone  2.5mm zone  4.5mm zone  4.5mm zone  TFRC 
L. lactis subsp. lactis DPC4268/ 303  LM17c  No zone  No zone  0.5mm zone  0.25mm zone  TFRC 
L. lactis subsp. lactis CSK2775  LM17c  No zone  2.5 mm  4.5 mm  4.5 mm  CSK  
L. lactis subsp. lactis CSK3594 LM17c  No zone No zone  4.5 mm  4.5 mm  CSK  
L. lactis subsp. lactis CSK3281  LM17c  No zone 2.5 mm  No zone  4 mm  CSK  
L. lactis subsp. lactis CSK3533  LM17c  No zone No zone  No zone  No zone  CSK  
Leuconoctos lactis DPC3838  MRSc  No zone  No zone  1.5mm zone  1.5mm zone  TFRC 
L. innocua DPC6578  GM17a  No zone  No zone  No zone  No zone  TFRC 
 875 
*Cultures grown anaerobically for up to 48h. aCultures grown at 37°C for up to 48h. bCultures grown at 35°C for up to 48h.cCultures 876 
grown at 30°C for up to 48h.  877 
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TABLE 3 Primer pairs used in this study 885 
 886 
Primer Sequence  Target gene(s) Size (bp) 
27-F 5’-GGGGAACAATCTTACCTA 
27-R 5’-ATTATTTTTATTGCATTCTACTA 
orf 27 326 
49-F 5’-CCAATACCCGCCAAAATAAAGT 
49-R 5’-CTAAGCGCAGAGGAAATACAACC 
orf 49 347 
51-F 5’-TTCTCAAAATCATCAAAATCAAGT 
51-R 5’-GTACGAACAGGAGCGAAAAA     
orf51 293 
52-F 5’- CCTAAGTTGTCTATTCGTGTCCA 
52-R 5’- ATTAGGTGAGTGCTCTGATTTTTC 
orf52 210 
nisA-F 5’- CAAAAGATTTTAACTTGGATTTG 
nisA-R 5’- ACGTGAATACTACAATGACAAG 
nisA 163 
nisFG-F 5’- GGTTTAATTTCTGCAGATACTG 
nisFG-R 5’- GTAATTATCCAGATCATTGCTG 
nisFEG 1573 
 887 
 888 
 889 
 890 
 891 
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TABLE 4 L. lactis transconjugants surveyed for bacteriophage sensitivity 904 
Bacteriophage L. lactis 
CSK2775 
L. lactis 
CSK3281 
(Nis+) 
L. lactis 
CSK3594 
(Ltn+) 
L. lactis 
CSK3533 
(Nis+Ltn+) 
5410F + + - - 
5163F + - - - 
5210 F + + + + 
5167F + - - - 
5385F 
(Bacteriophage 
cocktail) 
+ - - - 
5386F 
(Bacteriophage 
cocktail) 
+ + - - 
+ indicates bacteriophage sensitivity observed by a clearing of the bacterial population.  905 
- indicates bacteriophage insensitivity observed as growth (turbidity) of the bacterial population.  906 
 907 
 908 
 909 
 910 
 911 
 912 
 913 
 914 
 915 
 916 
 917 
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FIG 5 (C) 
 
Vat 5 L. lactis CSK3281, Lb. plantarum  LMG P-26358
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Vat 6 L. lactis CSK3594, Lb. plantarum  LMG P-26358
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